Josep Alfons Espinàs
Biographic Data
| ID | 7913067 |
|---|---|
| NAME | Josep Alfons Espinàs |
| GIVEN NAMES | Josep Alfons |
| FAMILY NAME | Espinàs |
| SIGNATURE | ESPINÀS J A |
| AFFILIATIONS | Institut d'Investigació Biomédica de Bellvitge |
| ORCID | 0000-0002-4027-7114 |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 6 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Validación De Los Conjuntos Mínimos Básicos De Datos Como Fuente De Información Diagnóstica Para La Evaluación De Programas De Cribado De Cáncer De Mama
Percepción Del Riesgo E Intención De Deshabituación Tabáquica en Participantes De Alto Riesgo De Cáncer Pulmonar en Un Estudio Piloto De Cribado
The Spoc[k] Profile (Screenings/Positives/Colonoscopies/[K]ancer)
No Excess Mortality up to 10 Years in Early Stages of Breast Cancer in Women Adherent to Oral Endocrine Therapy
Breast cancer (BC) is globally the most frequent cancer in women. Adherence to endocrine therapy (ET) in hormone-receptor-positive BC patients is active and voluntary for the first five years after diagnosis. This study examines the impact of adherence to ET on 10-year excess mortality (EM) in patients diagnosed with Stages I to III BC (N = 2297). Since sample size is an issue for estimating age- and stage-specific survival indicators, we develop…
Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain
Mortality from cardiovascular disease (CVD), second tumours, and other causes is of clinical interest in the long-term follow-up of breast cancer (BC) patients. Using a cohort of BC patients (N = 6758) from the cancer registries of Girona and Tarragona (north-eastern Spain), we studied the 10-year probabilities of death due to BC, other cancers, and CVD according to stage at diagnosis and hormone receptor (HR) status. Among the non-BC causes of d…
Exceso de mortalidad en las pacientes con cáncer de mama en estadios precoces en Tarragona y Gerona (España)
Analizar la supervivencia poblacional del cáncer de mama (CM) en estadios precoces, estimando la tendencia temporal del exceso de mortalidad (EM) a largo plazo en periodos anuales y quinquenales, y determinando, si es posible, una proporción de pacientes que puedan considerarse curadas. Se incluyó la cohorte de pacientes diagnosticadas de CM en estadios I y II antes de los 60 años de edad en Gerona y Tarragona (N = 2453). Se calcularon la supervi…
No prominent works on this page.
Exceso de mortalidad en las pacientes con cáncer de mama en estadios precoces en Tarragona y Gerona (España)
Analizar la supervivencia poblacional del cáncer de mama (CM) en estadios precoces, estimando la tendencia temporal del exceso de mortalidad (EM) a largo plazo en periodos anuales y quinquenales, y determinando, si es posible, una proporción de pacientes que puedan considerarse curadas. Se incluyó la cohorte de pacientes diagnosticadas de CM en estadios I y II antes de los 60 años de edad en Gerona y Tarragona (N = 2453). Se calcularon la supervi…
No Excess Mortality up to 10 Years in Early Stages of Breast Cancer in Women Adherent to Oral Endocrine Therapy
Breast cancer (BC) is globally the most frequent cancer in women. Adherence to endocrine therapy (ET) in hormone-receptor-positive BC patients is active and voluntary for the first five years after diagnosis. This study examines the impact of adherence to ET on 10-year excess mortality (EM) in patients diagnosed with Stages I to III BC (N = 2297). Since sample size is an issue for estimating age- and stage-specific survival indicators, we develop…
Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain
Mortality from cardiovascular disease (CVD), second tumours, and other causes is of clinical interest in the long-term follow-up of breast cancer (BC) patients. Using a cohort of BC patients (N = 6758) from the cancer registries of Girona and Tarragona (north-eastern Spain), we studied the 10-year probabilities of death due to BC, other cancers, and CVD according to stage at diagnosis and hormone receptor (HR) status. Among the non-BC causes of d…
Validación De Los Conjuntos Mínimos Básicos De Datos Como Fuente De Información Diagnóstica Para La Evaluación De Programas De Cribado De Cáncer De Mama
Percepción Del Riesgo E Intención De Deshabituación Tabáquica en Participantes De Alto Riesgo De Cáncer Pulmonar en Un Estudio Piloto De Cribado
The Spoc[k] Profile (Screenings/Positives/Colonoscopies/[K]ancer)
Breast Cancer Treatment Studies (3 works) · Medicine (3 works) · MEDLINE (3 works) · Breast cancer (2 works) · Cancer (2 works) · Cancer Risks and Factors (2 works) · Cohort (2 works) · Global Cancer Incidence and Screening (2 works) · Gynecology (2 works) · Internal Medicine (2 works)